Iveco Group 2023 Second Quarter Results
August 2, 2023
The following is an extract from the “Iveco Group 2023 Second Quarter and First Half Results” press release. The complete press release can be accessed
Press Releases
TMC Announces Corporate Update on Expected Timeline, Application Costs and Production Capacity Following Part II of the 28th Session of the International Seabed Authority
August 2, 2023
NEW YORK, Aug. 01, 2023 (GLOBE NEWSWIRE) — TMC the metals company Inc. (Nasdaq: TMC) (“TMC” or “the Company”), an explorer of lower-impact battery metals
Webuild: Progress in the construction of the new breakwater dam in Genoa
August 1, 2023
Unexploded ordnance clearance operations with saturation divers MILAN, Italy, Aug. 01, 2023 (GLOBE NEWSWIRE) — At the construction site of the new breakwater dam in
Eni teams up with Edison for remediation of former Montedison facilities
August 1, 2023
An agreement has been signed between the two companies to manage environmental remediation projects at several industrial sites MILAN, Italy, Aug. 01, 2023 (GLOBE NEWSWIRE)
Airnguru and Piano Launch Bundle and Ancillaries Price Optimization Engine with SKY Airline
August 1, 2023
Innovative solution leverages automated A/B testing technology to optimize airlines’ ancillaries aiming at total net revenue maximization SANTIAGO, Chile, Aug. 01, 2023 (GLOBE NEWSWIRE) —
Copenhagen Infrastructure Partners and Ignitis Group enter partnership in Estonia and Latvia
August 1, 2023
Ignitis Group’s subsidiary, Ignitis Renewables and Copenhagen Infrastructure Partners (CIP), through its New Markets Fund, have signed an agreement to collaborate exclusively on offshore wind
Fortinet Security Operations Solutions Use AI to Slash Time to Detect and Respond to Incidents from Three Weeks to One Hour
August 1, 2023
Report from Enterprise Strategy Group reveals that the integrated Fortinet SecOps Fabric automatically contains incidents in minutes or even seconds SUNNYVALE, Calif., Aug. 01, 2023
Zenas BioPharma Announces Publication of Phase 2 Study of Obexelimab, an Investigational Treatment for IgG4-Related Disease (IgG4-RD), in The Lancet Rheumatology
August 1, 2023
Study found obexelimab produced rapid, strong, and sustained clinical improvement, including complete clinical remission, in most patients with active IgG4-RD Results support the continued development
SimpleNexus, an nCino Company, Builds Integration with Finastra’s MortgagebotLOS
August 1, 2023
API integration connects SimpleNexus, an nCino Company, mobile-first homeownership solution with MortgagebotLOS to simplify U.S. home lending LEHI, Utah, Aug. 01, 2023 (GLOBE NEWSWIRE) —